We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.



Your filtered view of the latest news and analysis

  • Royalty boost for Vectura

    19 November 2014

    Speciality pharma group Vectura is seeing royalty income ramp up and the group boasts a strong product portfolio
  • ReNeuron heads West Tip Update

    17 November 2014

    Stem cell specialist ReNeuron (RENE) will next year apply for a new clinical trial in biotech's promised land - the US
  • Reckitt Benckiser in latest spin-out

    17 November 2014

    Reckitt Benckiser is the latest company to offload a division it considers surplus to requirements.
  • BTG delivers double-digit sales growth

    11 November 2014

    The commercial launch of a treatment for varicose veins underpinned a strong half for the speciality pharma group
  • Shire bosses buy up

    05 November 2014

    Following the collapse of the deal with AbbVie (US:ABBV), Shire's directors are buying up stock in the speciality pharma group.
  • Tissue Regenix in development mode

    31 October 2014

    Medical devices company Tissue Regenix is looking to build on the success of its product launch in the US this year
  • Speculation builds over Pfizer return

    31 October 2014

    Pfizer chief execuitve Ian Read has come to the defence of tax inversion deals, prompting speculation it will reapproach AstraZeneca.
  • GSK plans HIV float

    31 October 2014

    Drugs giant GlaxoSmithKline (GSK) is considering the float of a minority stake in its shared HIV business ViiV Healthcare.

Register today and get...

Register today and get...
Please note terms & conditions apply